The toxic oil syndrome: 20 years on

International Journal of Clinical Practice

Volumn 55, Issue 6, 2001, Pages 371-375

  Diggle, G E ^a  

^a Independent Consultant in Pharmaceutical Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (PHENYLAMINO) 1,2 PROPANEDIOL; 3 (PHENYLAMINO) LEVO ALANINE; ALANINE DERIVATIVE; ANILINE; PROPANEDIOL DERIVATIVE; RAPESEED OIL; TOXIC SUBSTANCE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; EOSINOPHILIA MYALGIA SYNDROME; FOOD; FRANCE; HUMAN; IMMUNOLOGY; MARKETING; MEDICAL RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; PUBLISHING; REGULATORY MECHANISM; SPAIN; STANDARD; TOXIC OIL SYNDROME;

ANILINE COMPOUNDS; DIETARY FATS, UNSATURATED; DISEASE OUTBREAKS; EOSINOPHILIA-MYALGIA SYNDROME; FOOD CONTAMINATION; HUMANS; PLANT OILS; RESPIRATION DISORDERS; SPAIN;

EID: 0034900442     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Diggle GE. The toxic oil syndrome: a continuing challenge. Adv Drug React Toxicol Rev 1995; 14(1): 11-35.
2. Duffy J. Eosinophilia-myalgia syndrome. Mayo Clin Proc 1992; 67: 1201-1202.
3. Posada de la Paz M, Philen RM, Abaitua-Borda I et al. Manufacturing processes at two French rape seed oil companies: possible relationships to toxic oil syndrome in Spain. Food Chem Toxicol 1991 ; 29: 797-803.
4. Posada de la Paz M, Abaitua-Borda I, Kilbourne EM. Late cases of toxic oil syndrome: evidence that the aetiological agent persisted in oil stored for up to one year. Food Chem Toxicol 1989; 27: 517-521.
5. Hard GC. Short-term adverse effeets in humans of ingested mineral oils, their additives and possible contaminants. Hum Exper Toxicol 2000; 19: 158-172.
6. Bell SA. Sander C. Kuntze I. Chatelaine R. The acute pathology of fatty aeid anil ides and linoleic diester of 3-phenylamino-l,2-propanediol in miee: possible implication as aetiologic agents for the toxic oil syndrome (TOS). Arch Toxicol 1999; 73(8-9): 493-495.
7. Posada de la Paz M, Philen RM, Schurz H et al. Epidemiologie evidence for a new class of compounds associated with toxic oil syndrome. Epidemiology 1999; 10(2): 130-134.
8. Mayeno AN. Belongia EA, Lin F et al. 3-(phenylamino)alanine, a novel aniline-derived amino acid associated with the cosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc 1992; 67(12): 1134-1139.
9. Mayeno AN. Bcnson LM, Naylor S el al. Biotransformation of 3-(phenylamino)-1.2-propancdiol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Chem Res Toxicol 1995:8(7): 911-916.
10. Ladona MG. Bujons J, Messeguer A el al. Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol. a compound present of samples related to toxic oil syndrome, in C57BL/6 and A/J mice. Chem Re,<, Toxicol 1999; 12(12): 1127-'ll.V7.
11. Posada de la Paz M, Castro M, Kilbourne EM et ai. Toxic oil syndrome: case reports associated with the ITH oil refinery in Sevilla. Food Chein Toxicol 1987:25(1): 87-90.
12. Hill RH. Schurz HH. Posada de la Pa/ M et al. Possible actiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-! .2-propanediol. Arch Environ Contain Toxicol 1995; 28(2): 259-264.
13. Po.sada de la Paz M. Philen RM, Schurz H et al. Epidemiologie evidence for a new class of compounds associated with toxic oil syndrome. Epidemiology 1999; 10(2): 130-134.
14. Posada de la Paz, Philen RM, Borda IA et al. Toxic oil syndrome: traceback of the toxic oil and evidence for a point-source epidemic. Food Chem Toxicol 1996:34(3): 251-257.
15. Beeson PB. Bass DA. In: Smith LH, Ed. The eoxinophil. Philadelphia: WB Saunders, 1977.
16. Beeson PB. Eosinophilia and the hypereosinophilic syndromes. In: Weatherall DJ, Lcdingham JGG. Warrell DA, Eds. The Oxford textbook of medicine. 2nd edn. Oxford: Oxford University Press, 1987.
17. WHO. Toxic oil syndrome and eosinophilia-myalgia syndrome: pursuing parallels in pathogenesis. Report of a WHO meeting. 8-10 May 1991. Washington DC. USA.